PRECIGEN INC's ticker is PGEN and the CUSIP is 74017N105. A total of 155 filers reported holding PRECIGEN INC in Q4 2020. The put-call ratio across all filers is 1.71 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,505,938 | +19.3% | 1,060,520 | -3.4% | 0.00% | – |
Q2 2023 | $1,262,331 | +15.1% | 1,097,679 | +6.1% | 0.00% | – |
Q1 2023 | $1,096,674 | -4.7% | 1,034,598 | +36.6% | 0.00% | – |
Q4 2022 | $1,151,297 | -27.3% | 757,432 | +1.5% | 0.00% | -100.0% |
Q3 2022 | $1,583,000 | +76.5% | 746,525 | +11.6% | 0.00% | – |
Q2 2022 | $897,000 | -41.2% | 668,824 | -7.5% | 0.00% | – |
Q1 2022 | $1,526,000 | -45.4% | 723,138 | -4.1% | 0.00% | -100.0% |
Q4 2021 | $2,797,000 | -24.1% | 753,705 | +2.1% | 0.00% | 0.0% |
Q3 2021 | $3,685,000 | -22.2% | 738,344 | +1.7% | 0.00% | -50.0% |
Q2 2021 | $4,734,000 | +17.8% | 725,930 | +24.4% | 0.00% | +100.0% |
Q1 2021 | $4,020,000 | -15.7% | 583,343 | +24.8% | 0.00% | -50.0% |
Q4 2020 | $4,768,000 | +200.6% | 467,411 | +3.2% | 0.00% | +100.0% |
Q3 2020 | $1,586,000 | -29.7% | 452,874 | +0.2% | 0.00% | 0.0% |
Q2 2020 | $2,257,000 | +48.4% | 452,123 | +1.1% | 0.00% | 0.0% |
Q1 2020 | $1,521,000 | – | 447,182 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Patient Capital Management, LLC | 13,753,176 | $19,529,510 | 1.15% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 2,078,220 | $2,951,072 | 0.60% |
EMFO, LLC | 425,000 | $603,500 | 0.57% |
Opaleye Management Inc. | 928,500 | $1,318,470 | 0.43% |
First Washington CORP | 646,575 | $918,137 | 0.37% |
Fore Capital, LLC | 426,791 | $606,043 | 0.26% |
SANDERS MORRIS HARRIS LLC | 410,000 | $582,200 | 0.12% |
MSD Partners, L.P. | 960,000 | $1,363,200 | 0.11% |
Virtus ETF Advisers LLC | 79,754 | $113,251 | 0.07% |
CHIRON CAPITAL MANAGEMENT, LLC | 55,850 | $79,307 | 0.07% |